Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan

Authors: Todd J Vento, David W Cole, Katrin Mende, Tatjana P Calvano, Elizabeth A Rini, Charla C Tully, Wendy C Zera, Charles H Guymon, Xin Yu, Kristelle A Cheatle, Kevin S Akers, Miriam L Beckius, Michael L Landrum, Clinton K Murray

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

The US military has seen steady increases in multidrug-resistant (MDR) gram-negative bacteria (GNB) infections in casualties from Iraq and Afghanistan. This study evaluates the prevalence of MDR GNB colonization in US military personnel.

Methods

GNB colonization surveillance of healthy, asymptomatic military personnel (101 in the US and 100 in Afghanistan) was performed by swabbing 7 anatomical sites. US-based personnel had received no antibiotics within 30 days of specimen collection, and Afghanistan-based personnel were receiving doxycycline for malaria chemoprophylaxis at time of specimen collection. Isolates underwent genotypic and phenotypic characterization.

Results

The only colonizing MDR GNB recovered in both populations was Escherichia coli (p=0.01), which was seen in 2% of US-based personnel (all perirectal) and 11% of Afghanistan-based personnel (10 perirectal, 1 foot+groin). Individuals with higher off-base exposures in Afghanistan did not show a difference in overall GNB colonization or MDR E. coli colonization, compared with those with limited off-base exposures.

Conclusion

Healthy US- and Afghanistan-based military personnel have community onset-MDR E. coli colonization, with Afghanistan-based personnel showing a 5.5-fold higher prevalence. The association of doxycycline prophylaxis or other exposures with antimicrobial resistance and increased rates of MDR E. coli colonization needs further evaluation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Boucher HW, Talbot GH, Bradley JS: Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009, 48: 1-12. 10.1086/595011.CrossRefPubMed Boucher HW, Talbot GH, Bradley JS: Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009, 48: 1-12. 10.1086/595011.CrossRefPubMed
2.
go back to reference Tängdén T, Cars O, Melhus A, Löwdin E: Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010, 54: 3564-3568. 10.1128/AAC.00220-10.CrossRefPubMedPubMedCentral Tängdén T, Cars O, Melhus A, Löwdin E: Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010, 54: 3564-3568. 10.1128/AAC.00220-10.CrossRefPubMedPubMedCentral
3.
go back to reference Moellering RC: NDM-1–a cause for worldwide concern. N Engl J Med. 2010, 363: 2377-2379. 10.1056/NEJMp1011715.CrossRefPubMed Moellering RC: NDM-1–a cause for worldwide concern. N Engl J Med. 2010, 363: 2377-2379. 10.1056/NEJMp1011715.CrossRefPubMed
4.
go back to reference Walsh TR, Weeks J, Livermore DM, Toleman MA: Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011, 11: 355-362. 10.1016/S1473-3099(11)70059-7.CrossRefPubMed Walsh TR, Weeks J, Livermore DM, Toleman MA: Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011, 11: 355-362. 10.1016/S1473-3099(11)70059-7.CrossRefPubMed
5.
go back to reference Siedelman L, Kline S, Duval S: Risk factors for community- and health facility-acquired extended-spectrum β-lactamase-producing bacterial infections in patients at the University of Minnesota medical center. Fairview. Am J Infect Control. 2012, 40: 849-853. 10.1016/j.ajic.2011.10.019.CrossRefPubMed Siedelman L, Kline S, Duval S: Risk factors for community- and health facility-acquired extended-spectrum β-lactamase-producing bacterial infections in patients at the University of Minnesota medical center. Fairview. Am J Infect Control. 2012, 40: 849-853. 10.1016/j.ajic.2011.10.019.CrossRefPubMed
6.
go back to reference Oncül O, Keskin O, Acar HV: Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect. 2002, 51: 47-51. 10.1053/jhin.2002.1205.CrossRefPubMed Oncül O, Keskin O, Acar HV: Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect. 2002, 51: 47-51. 10.1053/jhin.2002.1205.CrossRefPubMed
7.
go back to reference Hussey SM, Dukette PJ, Dunn SH: The 2010 Haiti earthquake: a pathology perspective aboard the USNS Comfort. Arch Pathol Lab Med. 2011, 135: 417-421.PubMed Hussey SM, Dukette PJ, Dunn SH: The 2010 Haiti earthquake: a pathology perspective aboard the USNS Comfort. Arch Pathol Lab Med. 2011, 135: 417-421.PubMed
8.
go back to reference Murray CK: Epidemiology of infections associated with combat-related injuries in Iraq and Afghanistan. J Trauma. 2008, 64: S232-238. 10.1097/TA.0b013e318163c3f5.CrossRefPubMed Murray CK: Epidemiology of infections associated with combat-related injuries in Iraq and Afghanistan. J Trauma. 2008, 64: S232-238. 10.1097/TA.0b013e318163c3f5.CrossRefPubMed
9.
go back to reference Scott P, Deye G, Srinivasan A: An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007, 44: 1577-1584. 10.1086/518170.CrossRefPubMed Scott P, Deye G, Srinivasan A: An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007, 44: 1577-1584. 10.1086/518170.CrossRefPubMed
10.
go back to reference Centers for Disease Control and Prevention (CDC): Notes from the field: detection of blaNDM-1 carbapenem resistance in a clinical isolate of Providencia stuartii in a U.S./coalition medical facility–Afghanistan, 2011. MMWR. 2011, 60: 756- Centers for Disease Control and Prevention (CDC): Notes from the field: detection of blaNDM-1 carbapenem resistance in a clinical isolate of Providencia stuartii in a U.S./coalition medical facility–Afghanistan, 2011. MMWR. 2011, 60: 756-
11.
go back to reference Sutter DE, Bradshaw LU, Simkins LH: High incidence of multidrug-resistant gram-negative bacteria recovered from Afghan patients at a deployed US military hospital. Infect Control Hosp Epidemiol. 2011, 32: 854-860. 10.1086/661284.CrossRefPubMed Sutter DE, Bradshaw LU, Simkins LH: High incidence of multidrug-resistant gram-negative bacteria recovered from Afghan patients at a deployed US military hospital. Infect Control Hosp Epidemiol. 2011, 32: 854-860. 10.1086/661284.CrossRefPubMed
12.
go back to reference Cockerill FR, Wikler MA, Alder J: Performace standards for antimicrobial susceptibility testing; twenty-second informational supplement (M100-S22). 2012, Wayne, PA: Clinical and Laboratory Standards Institute Cockerill FR, Wikler MA, Alder J: Performace standards for antimicrobial susceptibility testing; twenty-second informational supplement (M100-S22). 2012, Wayne, PA: Clinical and Laboratory Standards Institute
13.
go back to reference The National Healthcare Safety Network (NHSN) Manual: Patient Safety Component: Protocol – Multidrug-resistant Organism (MDRO) and Clostridium difficile-Associated Disease (CDAC) Module. 2008, Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, 1-29. The National Healthcare Safety Network (NHSN) Manual: Patient Safety Component: Protocol – Multidrug-resistant Organism (MDRO) and Clostridium difficile-Associated Disease (CDAC) Module. 2008, Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, 1-29.
14.
go back to reference Tenover FC, Arbeit RD, Goering RV: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995, 33: 2233-2239.PubMedPubMedCentral Tenover FC, Arbeit RD, Goering RV: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995, 33: 2233-2239.PubMedPubMedCentral
15.
go back to reference Ma L, Chang FY, Fung CP: Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb Drug Resist. 2005, 11: 31-39. 10.1089/mdr.2005.11.31.CrossRefPubMed Ma L, Chang FY, Fung CP: Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb Drug Resist. 2005, 11: 31-39. 10.1089/mdr.2005.11.31.CrossRefPubMed
16.
go back to reference Tribble DR, Conger NG, Fraser S: Infection-associated clinical outcomes in hospitalized medical evacuees following traumatic injury- Trauma Infectious Disease Outcome Study (TIDOS). J Trauma. 2011, 71: S33-S42. 10.1097/TA.0b013e318221162e.CrossRefPubMedPubMedCentral Tribble DR, Conger NG, Fraser S: Infection-associated clinical outcomes in hospitalized medical evacuees following traumatic injury- Trauma Infectious Disease Outcome Study (TIDOS). J Trauma. 2011, 71: S33-S42. 10.1097/TA.0b013e318221162e.CrossRefPubMedPubMedCentral
17.
go back to reference Weintrob AC, Roediger MP, Barber M: Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol. 2010, 31: 330-337. 10.1086/651304.CrossRefPubMed Weintrob AC, Roediger MP, Barber M: Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol. 2010, 31: 330-337. 10.1086/651304.CrossRefPubMed
18.
go back to reference Calbo E, Romani V, Xervacins M: Risk factors for community-onset urinary tract infections due to Escherichia coli harboring extended-spectrum β-lactamases. J Antimicrob Chemoth. 2006, 57: 780-783. 10.1093/jac/dkl035.CrossRef Calbo E, Romani V, Xervacins M: Risk factors for community-onset urinary tract infections due to Escherichia coli harboring extended-spectrum β-lactamases. J Antimicrob Chemoth. 2006, 57: 780-783. 10.1093/jac/dkl035.CrossRef
19.
go back to reference Herindrainy P, Randrianirina F, Ratovoson R: Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar. PLoS One. 2011, 6: e22738-10.1371/journal.pone.0022738.CrossRefPubMedPubMedCentral Herindrainy P, Randrianirina F, Ratovoson R: Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar. PLoS One. 2011, 6: e22738-10.1371/journal.pone.0022738.CrossRefPubMedPubMedCentral
20.
go back to reference Valverde A, Coque TM, Sanchez-Moreno MP: Dramatic increase in prevalence of fecal carriage of extended spectrum beta-lactamase-producing Enterobacteriaceae during non outbreak situations in Spain. J Clin Microbiol. 2004, 42: 4769-4775. 10.1128/JCM.42.10.4769-4775.2004.CrossRefPubMedPubMedCentral Valverde A, Coque TM, Sanchez-Moreno MP: Dramatic increase in prevalence of fecal carriage of extended spectrum beta-lactamase-producing Enterobacteriaceae during non outbreak situations in Spain. J Clin Microbiol. 2004, 42: 4769-4775. 10.1128/JCM.42.10.4769-4775.2004.CrossRefPubMedPubMedCentral
21.
go back to reference Friedmann R, Raveh D, Zartzer E: Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009, 30: 534-554. 10.1086/597505.CrossRefPubMed Friedmann R, Raveh D, Zartzer E: Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009, 30: 534-554. 10.1086/597505.CrossRefPubMed
22.
go back to reference Schnuriger B, Inaba K, Eberle BM: Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury. J Gastrointest Surg. 2010, 14: 1304-1310. 10.1007/s11605-010-1231-x.CrossRefPubMed Schnuriger B, Inaba K, Eberle BM: Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury. J Gastrointest Surg. 2010, 14: 1304-1310. 10.1007/s11605-010-1231-x.CrossRefPubMed
23.
go back to reference Bartlett JG, Bustetter LA, Gorbach SL, Onderdonk AB: Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora. Antimicrob Agents Chemoth. 1975, 7: 55-57. 10.1128/AAC.7.1.55.CrossRef Bartlett JG, Bustetter LA, Gorbach SL, Onderdonk AB: Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora. Antimicrob Agents Chemoth. 1975, 7: 55-57. 10.1128/AAC.7.1.55.CrossRef
24.
go back to reference Alestig K, Lidin-Janson G: The effect of doxycycline and tetracycline hydrochloride on the aerobic fecal flora. Sand J Infect Dis. 1975, 7: 265-271.CrossRef Alestig K, Lidin-Janson G: The effect of doxycycline and tetracycline hydrochloride on the aerobic fecal flora. Sand J Infect Dis. 1975, 7: 265-271.CrossRef
25.
go back to reference Jonsson M, Tunevall G: Selective pressure on tetracyclines on the faecal flora. Scand J Infect Dis. 1976, 9: 89-93. Jonsson M, Tunevall G: Selective pressure on tetracyclines on the faecal flora. Scand J Infect Dis. 1976, 9: 89-93.
26.
go back to reference Tuckman M, Petersen PJ, Howe AYM: Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials of tigecycline. Antmicrob Agents Chemoth. 2007, 51: 3205-3211. 10.1128/AAC.00625-07.CrossRef Tuckman M, Petersen PJ, Howe AYM: Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials of tigecycline. Antmicrob Agents Chemoth. 2007, 51: 3205-3211. 10.1128/AAC.00625-07.CrossRef
27.
go back to reference Jones CH, Tuckman M, Murphy E, Bradford PA: Identification and sequence of a tet(M) tetracycline resistance determinant homologue in clinical isolates of Escherichia coli. J Bacteriol. 2006, 188: 7151-7164. 10.1128/JB.00705-06.CrossRefPubMedPubMedCentral Jones CH, Tuckman M, Murphy E, Bradford PA: Identification and sequence of a tet(M) tetracycline resistance determinant homologue in clinical isolates of Escherichia coli. J Bacteriol. 2006, 188: 7151-7164. 10.1128/JB.00705-06.CrossRefPubMedPubMedCentral
28.
go back to reference Wu RB, Alexander TW, Li JQ, Munns K, Sharma R, McAllister TA: Prevalence and diversity of class 1 integrons and resistance genes in antimicrobial-resistant Escherichia coli originating from beef cattle administered subtherapeutic antimicrobials. J Applied Microbiol. 2011, 111: 511-523. 10.1111/j.1365-2672.2011.05066.x.CrossRef Wu RB, Alexander TW, Li JQ, Munns K, Sharma R, McAllister TA: Prevalence and diversity of class 1 integrons and resistance genes in antimicrobial-resistant Escherichia coli originating from beef cattle administered subtherapeutic antimicrobials. J Applied Microbiol. 2011, 111: 511-523. 10.1111/j.1365-2672.2011.05066.x.CrossRef
29.
go back to reference Mshana SE, Imirzalioflu C, Hossain H, Hain T, Domann E, Chakraborty T: Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a university hospital in Germany. BMC Infect Dis. 2009, 17: 97-CrossRef Mshana SE, Imirzalioflu C, Hossain H, Hain T, Domann E, Chakraborty T: Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a university hospital in Germany. BMC Infect Dis. 2009, 17: 97-CrossRef
30.
go back to reference Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N: Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother. 2006, 58: 665-668. 10.1093/jac/dkl309.CrossRefPubMed Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N: Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother. 2006, 58: 665-668. 10.1093/jac/dkl309.CrossRefPubMed
31.
go back to reference Perencevich EN, McGregor JC, Shardell M: Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol. 2008, 29: 1124-1131. 10.1086/592698.CrossRefPubMed Perencevich EN, McGregor JC, Shardell M: Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol. 2008, 29: 1124-1131. 10.1086/592698.CrossRefPubMed
32.
go back to reference Anderson DJ, Herve’ R, Chen LF: Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents. J Infect Dis. 2008, 197: 752-756. 10.1086/527486.CrossRefPubMed Anderson DJ, Herve’ R, Chen LF: Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents. J Infect Dis. 2008, 197: 752-756. 10.1086/527486.CrossRefPubMed
33.
go back to reference Rodríguez-Baño J, Navarro MD, Retamar P: lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis. 2012, 54: 167-174. 10.1093/cid/cir790.CrossRefPubMed Rodríguez-Baño J, Navarro MD, Retamar P: lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis. 2012, 54: 167-174. 10.1093/cid/cir790.CrossRefPubMed
34.
go back to reference Hospenthal DR, Murray CK, Andersen RC: Guidelines for the prevention of infections associated with combat-related injuries: 2011 update. J Trauma supplement. 2011, 71: S210-S234.CrossRef Hospenthal DR, Murray CK, Andersen RC: Guidelines for the prevention of infections associated with combat-related injuries: 2011 update. J Trauma supplement. 2011, 71: S210-S234.CrossRef
Metadata
Title
Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan
Authors
Todd J Vento
David W Cole
Katrin Mende
Tatjana P Calvano
Elizabeth A Rini
Charla C Tully
Wendy C Zera
Charles H Guymon
Xin Yu
Kristelle A Cheatle
Kevin S Akers
Miriam L Beckius
Michael L Landrum
Clinton K Murray
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-68

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine